Table 2

Clinical characteristics based on medical therapy at discharge

	DAPT (+) (n=170)	DAPT (−) (n=78)	P value	Cilostazol (+) (n=75)	Cilostazol (−) (n=173)	P value
Age, years	72.3±9.5	73.9±9.6	0.24	72.8±10.4	72.8±9.2	0.99
Male sex, %	77.6	66.7	0.067	73.3	74.6	0.84
Prior lower limb revascularisation, %	40.8	29.5	0.087	35.1	38.2	0.65
Prior coronary revascularisation, %	55	22.1	<0.001	26.7	52.6	<0.001
Hypertension, %	79.6	80.3	0.91	79.7	79.9	0.98
Diabetes mellitus, %	61.3	63.6	0.73	64.9	60.8	0.55
Dyslipidaemia, %	60.5	50	0.13	52.7	59.2	0.35
Haemodialysis, %	29.8	27.3	0.69	23	31.6	0.17
Smoking history, %	70.5	61	0.19	64.4	69.2	0.51
DAPT administration, %				40	80.9	<0.001
Cilostazol administration, %	17.6	57.7	<0.001
Warfarin administration, %	11.8	20.5	0.069	10.7	16.2	0.26